Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00392015 · ClinicalTrials.gov registry record · Phase 1
NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1
A Phase 1 study of Plasmodium Falciparum, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT00392015 is a Phase 1 study of Plasmodium Falciparum that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 59 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00392015, a Phase 1 study of Plasmodium Falciparum, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a new investigational malaria vaccine is safe, well tolerated and effective against experimental exposure to malaria when given to healthy people with no previous exposure to malaria. The vaccine consists of a modified form of a relatively common virus, adenovirus, that has been rendered incapable of replicating itself and modified to deliver the malaria gene of interest to the body's cells allowing the cell to manufacture the protein encoded by the gene and present it to the body's immune system in a more natural and presumably effective way.
Conditions Studied
Interventions
- BIOLOGICAL NMRC-M3V-Ad-PfCA
- BIOLOGICAL NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA
Study Locations (1)
Maryland
- Naval Medical Research Center (NMRC) Clinical Trials Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2006-10-12 |
| Est. Completion | 2017-09-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00392015
The ClinicalTrials.gov registry entry for NCT00392015 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Plasmodium Falciparum appearing as the primary indexed condition, and to 2 interventions - of which NMRC-M3V-Ad-PfCA is the first listed.
NCT00392015 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00392015 about?
NCT00392015 is a clinical study titled "NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1". The purpose of this study is to determine whether a new investigational malaria vaccine is safe, well tolerated and effective against experimental exposure to malaria when given to healthy people with no previous exposure to malaria. The vaccine consists of a modified form of a relatively common vir...
What is the current status of trial NCT00392015?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2006-10-12. Estimated completion is 2017-09-25.
What conditions does trial NCT00392015 study?
This clinical trial studies the following conditions: Plasmodium Falciparum.
What interventions are being tested in trial NCT00392015?
The interventions under investigation include: NMRC-M3V-Ad-PfCA (BIOLOGICAL), NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA (BIOLOGICAL).
Who is sponsoring clinical trial NCT00392015?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00392015 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plasmodium Falciparum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.